Background: Venous thromboembolisms (VTE) are a frequent concern for patients during their hospital stays. Many patients have limited ambulation which puts them at greater risk for developing a VTE in the hospital. VTE’s can be dangerous for patients and cause irreversible damage which is why it is significant to prevent them as much as possible. In current practice, both mechanical and chemical prophylaxis are used to prevent VTE’s, however chemical methods can lead to polypharmacy issues as well as increased risk of bleeding. The purpose of this project is to determine the most effective as well as the safest method for patients, and to ultimately discover whether mechanical or chemical prophylaxis is more successful in preventing VTE’s o...
International audienceBACKGROUND: Evidence-based guidelines recommend that acutely ill hospitalized ...
Two concepts relating to venous thromboembolism (VTE) prevention have recently emerged—‘‘appropriate...
BACKGROUND: Chemoprophylaxis is recommended for medical patients at moderate to high risk of venous ...
Background: Venous thromboembolisms (VTE) are a frequent concern for patients during their hospital ...
Background: Venous thromboembolism (VTE) is the most common unpredictable cause of in-hospital death...
OBJECTIVE: Venous thromboembolism (VTE) is a potentially preventable complication following surgery....
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Objective: To assess the effectiveness of different strategies for increasing the uptake of prophyla...
OBJECTIVE: To determine the rate of use of prophylaxis for venous thromboembolism in high-risk hospi...
Objective: To review the published clinical data on prophylaxis for thromboembolism in order to deve...
BACKGROUND: Evidence-based guidelines recommend that acutely ill hospitalized medical patients who a...
Hospital acquired venous thromboembolism (VTE) is a major source of morbidity and mortality, yet pro...
Venous thromboembolism affects between 200,000 and 600,000 Americans each year. VTE has become the t...
Venous thromboembolism (VTE) is an important cause of preventable morbidity and mortality in medical...
Georg Thieme Verlag KG Stuttgart · New York. Venous thromboembolism (VTE) remains a major cause of m...
International audienceBACKGROUND: Evidence-based guidelines recommend that acutely ill hospitalized ...
Two concepts relating to venous thromboembolism (VTE) prevention have recently emerged—‘‘appropriate...
BACKGROUND: Chemoprophylaxis is recommended for medical patients at moderate to high risk of venous ...
Background: Venous thromboembolisms (VTE) are a frequent concern for patients during their hospital ...
Background: Venous thromboembolism (VTE) is the most common unpredictable cause of in-hospital death...
OBJECTIVE: Venous thromboembolism (VTE) is a potentially preventable complication following surgery....
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Objective: To assess the effectiveness of different strategies for increasing the uptake of prophyla...
OBJECTIVE: To determine the rate of use of prophylaxis for venous thromboembolism in high-risk hospi...
Objective: To review the published clinical data on prophylaxis for thromboembolism in order to deve...
BACKGROUND: Evidence-based guidelines recommend that acutely ill hospitalized medical patients who a...
Hospital acquired venous thromboembolism (VTE) is a major source of morbidity and mortality, yet pro...
Venous thromboembolism affects between 200,000 and 600,000 Americans each year. VTE has become the t...
Venous thromboembolism (VTE) is an important cause of preventable morbidity and mortality in medical...
Georg Thieme Verlag KG Stuttgart · New York. Venous thromboembolism (VTE) remains a major cause of m...
International audienceBACKGROUND: Evidence-based guidelines recommend that acutely ill hospitalized ...
Two concepts relating to venous thromboembolism (VTE) prevention have recently emerged—‘‘appropriate...
BACKGROUND: Chemoprophylaxis is recommended for medical patients at moderate to high risk of venous ...